Abviris

Abviris is a private German diagnostics and biotechnology company focused on blood-based detection and monitoring of human papillomavirus-associated cancers. The company is best known for Prevo-Check, a rapid serological immunoassay designed to support early detection and post-treatment monitoring of HPV16-driven tumors, particularly in oral and head-and-neck settings. Abviris operates in oncology diagnostics rather than therapeutics, leveraging proprietary antibodies and HPV-related antigens to build immuno-oncology screening tools. The company appears to be venture-backed, commercially active, and centered on expanding adoption of its HPV biomarker testing products in clinical practice.